Related Experiment Video
Updated: Oct 24, 2025
Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
Phagocytosis Assay for α-Synuclein Fibril Uptake by Mouse Primary Microglia
Cuilian Du1,2, Feifan Zhang1, Claire Xi Zhang1
1Key Laboratory for the Neurodegenerative Disorders of the Chinese Ministry of Education, Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China.
Abstract:
Microglia are professional phagocytes in the brain and deficiency in their phagocytic activity plays an important role in Parkinson's disease. This protocol mainly describes the phagocytosis assay for uptake of α-synuclein preformed fibrils, a pathologic form of α-synuclein, by primary microglia.
Insights
This study details a method to measure microglia phagocytosis of alpha-synuclein fibrils, crucial for understanding Parkinson's disease. Assays assess the brain's immune cells' ability to clear toxic protein aggregates.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia are the primary immune cells in the central nervous system.
- Impaired microglial phagocytosis is implicated in the pathogenesis of neurodegenerative diseases like Parkinson's disease.
- Alpha-synuclein preformed fibrils are a key pathological hallmark in Parkinson's disease.
Purpose of the Study:
- To describe a standardized protocol for assessing the phagocytic capacity of primary microglia.
- To quantify the uptake of alpha-synuclein preformed fibrils by microglia.
Main Methods:
- Isolation and culture of primary microglia from rodent or human sources.
- Preparation and labeling of alpha-synuclein preformed fibrils.
- Incubation of microglia with labeled fibrils and subsequent quantification of cellular uptake via flow cytometry or microscopy.
Main Results:
- The protocol allows for reliable measurement of microglial phagocytosis of alpha-synuclein.
- Variability in phagocytic activity can be assessed under different experimental conditions.
Conclusions:
- This assay provides a valuable tool for studying microglial function in Parkinson's disease models.
- Understanding phagocytosis defects may lead to novel therapeutic strategies for Parkinson's disease.
